Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Sep. 30, 2024	Dec. 31, 2023
Assets
Cash and cash equivalents		$ 9,060	$ 9,397
Accounts receivable, net		5,240	25,304
Non-trade receivable		4,322	961
Related party receivable		644
Inventory		12,374	6,517
Prepaid expenses and other current assets		2,224	1,608
Total current assets		33,864	43,787
Property and equipment, net		239	71
Contract fulfillment assets		12,063	9,232
Other assets		2,981	2,953
Total assets		49,147	56,043
Liabilities and stockholders’ equity
Accounts payable		9,056	19,847
Accrued liabilities		23,128	12,300
Total current liabilities		32,184	32,147
Income tax payable		1,614	1,528
Total liabilities		33,798	33,675
Commitments and contingencies (Note 8)
Stockholders’ equity
Common stock, $0.001 par value per share; 100,000,000 shares authorized: and 4,871,639 and 4,426,867 shares issued and outstanding at September 30, 2024, and December 31, 2023, respectively	[1]	5	4
Preferred stock, $0.001 par value per share, 5,000,000 shares authorized, and no shares issued and outstanding at September 30, 2024, and December 31, 2023, respectively
Additional paid-in capital	[1]	277,338	272,324
Accumulated deficit		(261,994)	(249,960)
Total stockholders’ equity		15,349	22,368
Total liabilities and stockholders’ equity		$ 49,147	$ 56,043

[1] Adjusted retroactively to reflect the 1-for-10 reverse stock split that became effective on July 17, 2024, see Note 1.